South African billionaire-led firm to snap up Viagra and others for $280 million
Aspen Pharmacare is a branded pharmaceutical company.
Aspen Pharmacare
South African billionaire Stephen Saad’s Aspen Pharma stake falls by $29 million in 27 days
Saad’s stake in Aspen Pharma has fallen by $29 million as investors factor in the challenging operating conditions in the pharmaceutical industry.
South African billionaire Stephen Saad rakes in $132 million as Aspen shares skyrocket
With a net worth of $1.2 billion, Saad’s 12.5-percent stake in Aspen Pharmacare accounts for a significant portion of his wealth.
South African pharma tycoon Stephen Saad gains $37.1 million from Aspen shares
Saad owns a significant 12.5-percent stake in Aspen Pharmacare Holdings.
South African billionaire Stephen Saad’s Aspen secures $30 million grant to make vaccines
Aspen Pharmacare Holdings Limited is a South African multinational pharmaceutical holding company.
South African exec Gus Attridge loses $10 million in 13 days from stake in Aspen Pharmacare
Attridge owns a 4.26-percent stake in the company.
South African multimillionaire Gus Attridge’s stake in Aspen now worth $171 million
Aspen Pharmacare is a multinational pharmaceutical holding company.
South African pharma billionaire Stephen Saad’s Aspen closes $1.26-billion credit facility
Aspen Pharmacare Holdings Limited is a South African multinational pharmaceutical holding company.
South African pharma billionaire Stephen Saad’s Aspen signs vaccines deal with India’s Serum Institute
Saad owns a 12.5-percent stake in Aspen worth $566 million.
South African-born billionaire Patrick Soon-Shiong rents out part of vaccine plant as demand declines
Earlier this year, ImmunityBio opened a plant in South Africa under the name Nant SA.
South African billionaire Stephen Saad loses more than $250 million from Aspen Pharma stake
Saad owns a 12.5-percent stake in Aspen Pharmacare Holdings, worth $566 million.
South African billionaire Stephen Saad’s Aspen could cut COVID-19 vaccine capacity
Saad controls a 12.5-percent stake in the leading drug company.
South African billionaire Stephen Saad’s Aspen concludes COVID-19 vaccine deal
The vaccine will be marketed as Aspenovax.
South African tycoon Stephen Saad’s Aspen partners with Siemens to boost vaccine production for Africa
The collaboration will enable Africa’s largest drugmaker to increase its production capacity to meet the rising vaccine demand in Africa.
South African billionaire Stephen Saad’s stake in Aspen Pharmacare gains $168.9 million
Aspen is a global multinational pharmaceutical company.